Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy

Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy

BackgroundTo identify whether adjuvant transarterial chemoembolization (TACE) can improve prognosis in HCC patients with a low risk of recurrence (tumor size ≤ 5 cm, single nodule, no satellites, and no microvascular or macrovascular invasions) after hepatectomy.MethodsThe data of 489 HCC patients w...

Full description

Bibliographic Details
Main Authors: Long-Hai Feng, Yu-Yao Zhu, Jia-Min Zhou, Miao Wang, Wei-Qi Xu, Ti Zhang, An-Rong Mao, Wen-Ming Cong, Hui Dong, Lu Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
hepatectomy
postoperative adjuvant TACE
low risk of recurrence
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1104492/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1104492/full

Similar Items